Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Synergistic senolytic-regenerative therapy significantly extends healthspan and lifespan.

Journal of translational medicine·2026

Same author

Hematopoietic stem cells from organ donors lead to long-term multi-lineage engraftment in NSG mice.

Bone marrow transplantation·2026

Same author

Development and validation of a potency assay matrix for optimized and consistent manufacture of clinical mesenchymal stem/stromal cells.

Frontiers in immunology·2026

Same author

Biomimetic and personalized nanovaccines in cancer immunotherapy: Design innovations, translational challenges, and future directions.

Journal of advanced research·2026

Same author

Cryopreserved organ donor bone marrow achieves robust engraftment and chimerism in mismatched allogeneic transplantation.

Cytotherapy·2025

Same author

Reduction of solid tumors by senescent cell immunization.

Journal of translational medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Combination stem cell therapy for heart failure.

Thomas E Ichim¹, Fabio Solano, Fabian Lara

¹Medistem Inc, San Diego, USA. thomas.ichim@gmail.com

International Archives of Medicine

|April 20, 2010

Summary

This summary is machine-generated.

Stem cell therapy offers moderate benefits for congestive heart failure (CHF) patients ineligible for transplantation. Optimization strategies include enhancing stem cell migration, activity, and combining therapies for improved outcomes.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Related Experiment Videos

Last Updated: Jun 13, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Area of Science:

Regenerative Medicine
Cardiovascular Research
Stem Cell Biology

Background:

Congestive heart failure (CHF) patients not eligible for transplantation have limited treatment options.
Stem cell therapy, including autologous bone marrow and mobilized peripheral blood, has been clinically applied since 2001.
Over 1000 patients have received cellular therapy in randomized trials, showing moderate, statistically significant benefits.

Purpose of the Study:

To discuss optimization strategies for stem cell therapy in congestive heart failure.
To explore methods for increasing stem cell migration to the heart.
To investigate augmenting stem cell activity and combining therapies to create a therapeutic niche.

Main Methods:

Review of existing stem cell therapy approaches for congestive heart failure.
Discussion of strategies to enhance stem cell efficacy.
Presentation of a case report detailing a combination stem cell protocol.

Main Results:

Stem cell therapy demonstrates a moderate but statistically significant benefit in congestive heart failure patients.
Optimization is a crucial next step in advancing this therapeutic approach.
A combination protocol using cord blood CD34 cells and mesenchymal-like stem cells was applied.

Conclusions:

Optimizing stem cell therapy is essential for improving outcomes in congestive heart failure.
Strategies include enhancing stem cell migration and activity, and combining cell types.
A case report illustrates the potential of a combined stem cell approach.